StockData
Twist Bioscience Corp logo

Twist Bioscience Corp (TWST) stock

TWSTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Nov 16, 2026Score 13/30231% above fair value
$116.35+4.35 (+3.88%)

Close on Nov 18, 2026Market cap $7.30BP/E –Yield –

Twist Bioscience operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Twist Bioscience's operating income for the twelve months ending Jun 30, 2026 was -$144.98M. For fiscal 2025 it was -$136.26M. The highest annual figure on record is -$58.48M in fiscal 2017.

Annual operating income

PeriodPeriod endValueChange
FY2025Sep 30, 2025-$136.26M–
FY2024Sep 30, 2024-$220.83M–
FY2023Sep 30, 2023-$217.16M–
FY2022Sep 30, 2022-$234.78M–
FY2021Sep 30, 2021-$152.73M–
FY2020Sep 30, 2020-$140.08M–
FY2019Sep 30, 2019-$108.85M–
FY2018Sep 30, 2018-$70.56M–
FY2017Sep 30, 2017-$58.48M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026-$36.28M–
Q2 FY2026CQ1 2026Mar 31, 2026-$45.86M–
Q1 FY2026CQ4 2025Dec 31, 2025-$32.90M–
Q4 FY2025CQ3 2025Sep 30, 2025-$29.93M–
Q3 FY2025CQ2 2025Jun 30, 2025-$30.12M–
Q2 FY2025CQ1 2025Mar 31, 2025-$41.56M–
Q1 FY2025CQ4 2024Dec 31, 2024-$34.64M–
Q4 FY2024CQ3 2024Sep 30, 2024-$36.04M–
Q3 FY2024CQ2 2024Jun 30, 2024-$88.92M–
Q2 FY2024CQ1 2024Mar 31, 2024-$48.89M–
Q1 FY2024CQ4 2023Dec 31, 2023-$46.98M–
Q4 FY2023CQ3 2023Sep 30, 2023-$50.11M–
Q3 FY2023CQ2 2023Jun 30, 2023-$60.78M–
Q2 FY2023CQ1 2023Mar 31, 2023-$61.64M–
Q1 FY2023CQ4 2022Dec 31, 2022-$44.63M–
Q4 FY2022CQ3 2022Sep 30, 2022-$56.87M–
Q3 FY2022CQ2 2022Jun 30, 2022-$61.16M–
Q2 FY2022CQ1 2022Mar 31, 2022-$60.80M–
Q1 FY2022CQ4 2021Dec 31, 2021-$55.94M–
Q4 FY2021CQ3 2021Sep 30, 2021-$39.81M–
Q3 FY2021CQ2 2021Jun 30, 2021-$42.12M–
Q2 FY2021CQ1 2021Mar 31, 2021-$38.00M–
Q1 FY2021CQ4 2020Dec 31, 2020-$32.79M–
Q4 FY2020CQ3 2020Sep 30, 2020-$23.97M–
Q3 FY2020CQ2 2020Jun 30, 2020-$28.20M–
Q2 FY2020CQ1 2020Mar 31, 2020-$32.09M–
Q1 FY2020CQ4 2019Dec 31, 2019-$55.83M–
Q4 FY2019CQ3 2019Sep 30, 2019-$31.57M–
Q3 FY2019CQ2 2019Jun 30, 2019-$28.12M–
Q2 FY2019CQ1 2019Mar 31, 2019-$26.26M–
Q1 FY2019CQ4 2018Dec 31, 2018-$22.90M–
Q4 FY2018CQ3 2018Sep 30, 2018-$19.70M–
Q3 FY2018CQ2 2018Jun 30, 2018-$17.49M–
Q2 FY2018CQ1 2018Mar 31, 2018-$16.62M–
Q1 FY2018CQ4 2017Dec 31, 2017-$16.75M–

More Twist Bioscience figures

See a number that looks wrong?